Cargando…
Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal change...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508960/ https://www.ncbi.nlm.nih.gov/pubmed/35862203 http://dx.doi.org/10.1161/STROKEAHA.122.038846 |
_version_ | 1784797131318493184 |
---|---|
author | Yamauchi, Hiroshi Kagawa, Shinya Kusano, Kuninori Ito, Miki Okuyama, Chio |
author_facet | Yamauchi, Hiroshi Kagawa, Shinya Kusano, Kuninori Ito, Miki Okuyama, Chio |
author_sort | Yamauchi, Hiroshi |
collection | PubMed |
description | Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal changes in the thalamus in vivo. The purpose of this study was to determine whether secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease. METHODS: We retrospectively analyzed the data of 140 patients with unilateral cerebral infarction ipsilateral to internal carotid artery or middle cerebral artery disease. All patients had quantitative measurements of (11)C-flumazenil binding potential (FMZ-BP), cerebral blood flow, and cerebral metabolic rate of oxygen using positron emission tomography in the chronic stage. Region of interest analysis was performed using NeuroFlexer—an automated region of interest analysis software using NEUROSTAT. RESULTS: In the thalamus ipsilateral to the infarcts, the values of FMZ-BP, cerebral blood flow, and cerebral metabolic rate of oxygen were significantly lower than those in the contralateral thalamus. Significant correlations were found between the ipsilateral-to-contralateral ratio of FMZ-BP and the ipsilateral-to-contralateral ratio of cerebral blood flow or cerebral metabolic rate of oxygen in the thalamus. Patients with corona radiata infarcts and striatocapsular infarcts had significantly decreased ipsilateral-to-contralateral FMZ-BP ratio in the thalamus compared with those without. The ipsilateral-to-contralateral ratio of FMZ-BP in the thalamus was significantly correlated with the ipsilateral-to-contralateral cerebral metabolic rate of oxygen ratio in the frontal cortex and showed a significant negative correlation with the number of perseverative errors on the Wisconsin Card Sorting Test. CONCLUSIONS: Secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease, which may be associated with frontal lobe dysfunction. |
format | Online Article Text |
id | pubmed-9508960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-95089602022-09-26 Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study Yamauchi, Hiroshi Kagawa, Shinya Kusano, Kuninori Ito, Miki Okuyama, Chio Stroke Original Contributions Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal changes in the thalamus in vivo. The purpose of this study was to determine whether secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease. METHODS: We retrospectively analyzed the data of 140 patients with unilateral cerebral infarction ipsilateral to internal carotid artery or middle cerebral artery disease. All patients had quantitative measurements of (11)C-flumazenil binding potential (FMZ-BP), cerebral blood flow, and cerebral metabolic rate of oxygen using positron emission tomography in the chronic stage. Region of interest analysis was performed using NeuroFlexer—an automated region of interest analysis software using NEUROSTAT. RESULTS: In the thalamus ipsilateral to the infarcts, the values of FMZ-BP, cerebral blood flow, and cerebral metabolic rate of oxygen were significantly lower than those in the contralateral thalamus. Significant correlations were found between the ipsilateral-to-contralateral ratio of FMZ-BP and the ipsilateral-to-contralateral ratio of cerebral blood flow or cerebral metabolic rate of oxygen in the thalamus. Patients with corona radiata infarcts and striatocapsular infarcts had significantly decreased ipsilateral-to-contralateral FMZ-BP ratio in the thalamus compared with those without. The ipsilateral-to-contralateral ratio of FMZ-BP in the thalamus was significantly correlated with the ipsilateral-to-contralateral cerebral metabolic rate of oxygen ratio in the frontal cortex and showed a significant negative correlation with the number of perseverative errors on the Wisconsin Card Sorting Test. CONCLUSIONS: Secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease, which may be associated with frontal lobe dysfunction. Lippincott Williams & Wilkins 2022-07-06 2022-10 /pmc/articles/PMC9508960/ /pubmed/35862203 http://dx.doi.org/10.1161/STROKEAHA.122.038846 Text en © 2022 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Original Contributions Yamauchi, Hiroshi Kagawa, Shinya Kusano, Kuninori Ito, Miki Okuyama, Chio Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title | Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title_full | Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title_fullStr | Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title_full_unstemmed | Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title_short | Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study |
title_sort | neuronal alterations in secondary thalamic degeneration due to cerebral infarction: a (11)c-flumazenil positron emission tomography study |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508960/ https://www.ncbi.nlm.nih.gov/pubmed/35862203 http://dx.doi.org/10.1161/STROKEAHA.122.038846 |
work_keys_str_mv | AT yamauchihiroshi neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy AT kagawashinya neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy AT kusanokuninori neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy AT itomiki neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy AT okuyamachio neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy |